FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT OTW CORONARY STENT SYSTEM

MDR report key: 2023556 · Received March 16, 2011

Report

Report Number
9612164-2011-00071
Event Type
Injury
Date Received
March 16, 2011
Date of Event
February 18, 2011
Report Date
February 18, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS: MI, TVR.

Description of Event or Problem · 1

IT WAS CONFIRMED THAT DURING THE REVASCULARIZATION ON THE SAME DAY AS THE REPORTED MI THERE WERE TWO UNKNOWN BRAND STENTS IMPLANTED IN THE VEIN GRAFT OFF THE 1ST DIAGONAL BRANCH TO TREAT VEIN GRAFT STENOSIS.

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE THE PATIENT HAD TWO ENDEAVOR SPRINT OVER-THE-WIRE (OTW) STENTS IMPLANTED TO THE PROXIMAL LCX AND ONE ENDEAVOR SPRINT OTW STENT IMPLANTED TO THE LEFT MAIN. TWO DAYS POST INDEX PROCEDURE THE PATIENT IS REPORTED TO HAVE SUFFERED A MYOCARDIAL INFARCTION (NON-ST SEGMENT ELEVATION). THE INVESTIGATOR ASSESSED THAT THE TARGET LESION WAS NOT INVOLVED. THE PATIENT WAS SCHEDULED TO UNDERGO A STAGED PROCEDURE TO THE LAD. THE PHYSICIAN COULD NOT PASS THE TORTUOUS VEIN GRAFT TO REACH THE LAD AND A STENT WAS PLACED IN THE VEIN GRAFT. WHILE ATTEMPTING TO PROCEED THE LAD A PERFORATION IS REPORTED TO HAVE OCCURRED. THE PERFORATION SPONTANEOUSLY SEALED AND THE REST OF THE PROCEDURE WAS STOPPED. THE INVESTIGATOR ASSESSED THAT THERE WAS NO RELATIONSHIP BETWEEN THE EVENT AND THE STUDY DEVICE OR STUDY DRUG. THE PATIENT RECOVERED WITH TREATMENT AND NO OTHER CLINICAL SEQUELAE WERE REPORTED. REF MFR REPORT NUMBER 9612164-2011-00072.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT OTW CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA UNK

Patients

Seq Age Sex Outcome Treatment
1 82 YR Male Required Intervention CLOPIDOGREL| ASPIRIN